Answers are grounded in this paper and cite their sources.
The blood-brain barrier (BBB) serves as a highly selective barrier separating the central nervous system from the systemic circulation. Although contributing to neurological health, the BBB restricts the ability of drugs to reach their site of action and thus presents a major challenge to the treatment of neurological disorders. Advances in our understanding of the complexity of the BBB have fostered development of novel pharmacometric models and drug delivery strategies to better predict and improve therapeutic access.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: